Join to view full profile
One Hospital DrColumbia, MO 65212
Phone+1 573-882-1201
Dr. Hammer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Hammer is a pathologist based in Columbia, MO, with subspecialties in hematopathology, anatomic pathology, clinical pathology, and surgical pathology. He graduated from the Medical University of South Carolina in 1988 and completed his residency in pathology, both anatomic and clinical, and a fellowship in hematopathology at Vanderbilt University Medical Center. His areas of experience include clinical decision support and digital pathology. Dr. Hammer has authored several publications, including articles on AML treatment, gene relationship mining, plasma cell analysis, and the application of artificial intelligence in biomedical literature.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematopathology, 1988 - 1996- Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 1988 - 1995
Medical University of South CarolinaClass of 1988
Certifications & Licensure
TX State Medical License 1996 - 2028
MO State Medical License 2013 - 2027
FL State Medical License 2012 - 2016
MD State Medical License 2011 - 2014
OH State Medical License 2011 - 2014
TN State Medical License 1989 - 2014
VA State Medical License 2011 - 2014
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
- Join now to see all
Publications & Presentations
PubMed
- Single-cohort next-generation sequencing analysis of 713 anaplastic thyroid carcinomas: unreported gene alterations and actionable targets.Xiaoming Zhang, Naiwei Chen, Sarah Claxton, Mikhail Kovalenko, Dean C Pavlick
American Journal of Clinical Pathology. 2026-08-04 - Stabilization of HIF-1α using the prolyl hydroxylase inhibitor roxadustat reduces gastrointestinal graft-versus-host disease.Vasantharaja Raguraman, Shanid Mohiyuddin, Tyler Plank, Catherine Benge, Linnea Banker
Scientific Reports. 2026-06-27 - Polymorphic EBV-positive post-transplant lymphoproliferative disorder of the colon mimicking EBV-positive mucocutaneous ulcer: a case report.McKenzie Wallace, Alicia Dessain, Soumya Mikkilineni, Richard D Hammer
Journal of Hematopathology. 2026-06-13
Press Mentions
Heart Drug Affects Leukemia Responsiveness to ChemotherapyJune 27th, 2024- Study Discovers High Prevalence of COVID & Flu Co-InfectionsNovember 7th, 2022
- Study Finds High Prevalence of COVID-19 and Flu Co-Infections During 2021-2022 Flu SeasonNovember 2nd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
